BTIG analyst Mark Massaro lowered the firm’s price target on NeoGenomics (NEO) to $18 from $21 and keeps a Buy rating on the shares. The stock ...

BTIG keeps a Buy rating on Mersana Therapeutics (MRSN) with a $6 price target after the company presented data for Emi-Le from the Phase I ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to ...

FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.25 or -9.62% from the prior close of $2.6. The stock opened at $2.52 and touched a low of $2.32 ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

Last week, BTIG analyst Jake Fuller reiterated a Buy rating on Uber Technologies (UBER) stock with a price target of $90. The analyst remains bullish on the ride-hailing company but expects its Q4 ...

BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, the firm’s receipt data was “more ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical ...

https://www.tipranks.com/news/the-fly/ardent-health-price-target-lowered-to-21-from-22-at-truist BTIG analyst Marie Thibault raised the firm’s price target on ...